Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-23

Clinical Trial Update: Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial is evaluating the gut microbiome in patients with POEMS syndrome and other plasma cell disorders; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Plasma Cell Disorders | Status: RECRUITING